Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 25, 2025
Victor Leung, Junine Toy, Peter Phillips, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
May 20, 2025
Doxycycline postexposure prophylaxis to prevent bacterial sexually transmitted infections
Victor Leung, Junine Toy, Peter Phillips, et al.
AIDS (London, England)
|
February 5, 2011
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia
Junine Toy, Pierre Giguère, Stephen Kravcik, et al.
The Canadian Journal of Hospital Pharmacy
|
July 18, 2022
Risk Factors, Screening, Diagnosis, and Treatment of Osteoporosis in HIV-Infected Adults in an HIV Primary Care Clinic
Kevin Kwok, Caitlin Olatunbosun, Erin Ready, et al.
Health Science Reports
|
March 2, 2026
Identifying Subgroups of People Living With HIV in British Columbia, Canada Based on Sexually Transmitted and Blood-Borne Infection Testing and Diagnostic Laboratory Data: A Retrospective Cohort Study
Amanda M Yonkman, Scott D Emerson, Paul Sereda, et al.
Tropical Medicine and Infectious Disease
|
March 26, 2025
Generalized Treatment as Prevention Plus Focused Pre-Exposure Prophylaxis Is the Key to Controlling HIV/AIDS
Julio S G Montaner, Viviane D Lima, Kate A Salters, et al.
Social Science & Medicine (1982)
|
May 4, 2024
The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
Lalani L Munasinghe, Weijia Yin, Hasan Nathani, et al.
Current HIV Research
|
September 7, 2013
Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulation
Andy Mtambo, Marianne Harris, Junine Toy, et al.
Therapeutic Drug Monitoring
|
February 9, 2021
Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication
Birgit E Watson, Kieran Atkinson, Kathleen Auyeung, et al.
Plos Medicine
|
December 9, 2025
Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation study
Angela McLaughlin, Junine Toy, Vincent Montoya, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 25, 2025
Victor Leung, Junine Toy, Peter Phillips, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
May 20, 2025
Doxycycline postexposure prophylaxis to prevent bacterial sexually transmitted infections
Victor Leung, Junine Toy, Peter Phillips, et al.
AIDS (London, England)
|
February 5, 2011
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia
Junine Toy, Pierre Giguère, Stephen Kravcik, et al.
The Canadian Journal of Hospital Pharmacy
|
July 18, 2022
Risk Factors, Screening, Diagnosis, and Treatment of Osteoporosis in HIV-Infected Adults in an HIV Primary Care Clinic
Kevin Kwok, Caitlin Olatunbosun, Erin Ready, et al.
Health Science Reports
|
March 2, 2026
Identifying Subgroups of People Living With HIV in British Columbia, Canada Based on Sexually Transmitted and Blood-Borne Infection Testing and Diagnostic Laboratory Data: A Retrospective Cohort Study
Amanda M Yonkman, Scott D Emerson, Paul Sereda, et al.
Tropical Medicine and Infectious Disease
|
March 26, 2025
Generalized Treatment as Prevention Plus Focused Pre-Exposure Prophylaxis Is the Key to Controlling HIV/AIDS
Julio S G Montaner, Viviane D Lima, Kate A Salters, et al.
Social Science & Medicine (1982)
|
May 4, 2024
The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
Lalani L Munasinghe, Weijia Yin, Hasan Nathani, et al.
Current HIV Research
|
September 7, 2013
Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulation
Andy Mtambo, Marianne Harris, Junine Toy, et al.
Therapeutic Drug Monitoring
|
February 9, 2021
Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication
Birgit E Watson, Kieran Atkinson, Kathleen Auyeung, et al.
Plos Medicine
|
December 9, 2025
Heterogeneous impacts of HIV pre-exposure prophylaxis (PrEP) on drug resistance and phylogenetic cluster transmission dynamics in British Columbia, Canada: A retrospective cohort and simulation study
Angela McLaughlin, Junine Toy, Vincent Montoya, et al.
Page
of 3